Clinical Trials Logo

Clinical Trial Summary

Based on many previous data proving hypervolemia in chronic hemodialysis patients could lead to sleep apnea and poor sleep quality. The investigators conduct this trial to evaluate whether more accurate dry weight assessment with BIA in these patients can lead to better sleep quality (measured by sleep actigraphy and questionnaires). The investigators will enroll 30 chronic hemodialysis patients in hemodialysis unit of Ramathibodi hospital whose age > 18 years with subclinical hypervolemic status and baseline Pittsburgh sleep quality index (PSQI) score > 5 into study. Patients with bed-ridden status, alteration of consciousness and unstable hemodynamics will be excluded. Then eligible patients will be randomized into 2 groups, BIA-guided and standard clinical guided dry weight assessment. The investigators will assess participants' dry weight at beginning of study, 3rd month and 6th month. Sleep actigraphy parameters (eg. total sleep time, sleep efficiency), sleep questionnaires score, left ventricular mass index by echocardiography, ambulatory blood pressure monitoring and blood chemistry results were collected at beginning of study, the end of 1st, 3rd and 6th month. The primary outcome is change of sleep actigraphy parameters between the groups. The secondary outcomes are change of sleep questionnaires scores, change of left ventricular mass index, change of ambulatory BP monitoring and also cardiovascular complications between groups.


Clinical Trial Description

This randomized control trial aim to detect the better volume control guided by bioimpedance may improve ambulatory blood pressure control, sleep quality and left ventricular hypertrophy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02825589
Study type Interventional
Source Mahidol University
Contact
Status Completed
Phase N/A
Start date July 2016
Completion date February 2017

See also
  Status Clinical Trial Phase
Completed NCT01947673 - Mechanisms of Intradialytic Hypertension N/A
Not yet recruiting NCT03634904 - Serum Ceftazidime Concentrations in Hemodialysis Patients N/A
Terminated NCT01982864 - Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients. Phase 4
Completed NCT01448174 - Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients Phase 4
Completed NCT01421771 - Blood Pressure in Dialysis Patients N/A
Completed NCT01722695 - Performance Comparison of Revaclear With Larger Dialyzer N/A
Withdrawn NCT01015313 - Effects of Intensified Sodium Management in Hemodialysis Patients N/A
Completed NCT02259413 - Effect of an Exercise Rehabilitation Program on Symptoms in Hemodialysis N/A
Not yet recruiting NCT02452788 - Pharmaceutical Care in Ambulatory Hemodialysis Patients N/A
Recruiting NCT01356563 - Efficacy Study of Pharmacist Intervention on Medication-related Problems in Hemodialysis Patients N/A
Completed NCT01320202 - Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients Phase 3
Completed NCT01181544 - A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis N/A
Completed NCT02285075 - Temocillin Pharmacokinetic in Hemodialysis Phase 4
Completed NCT00890045 - Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study N/A
Not yet recruiting NCT02264964 - Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis N/A
Completed NCT01214928 - Hemodialysis Vitamin D Pilot N/A
Terminated NCT01312441 - Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D Phase 4
Completed NCT00967993 - Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease Phase 2
Completed NCT01981603 - Transplant Navigator Dissemination N/A
Completed NCT01578421 - Investigation on the Middle Size Molecule Elimination Characteristics of the FXCorDiax 100 in Relation to the FX 100 and the Polyflux 210 H Dialyser N/A